Sangamo Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
31.12.24
/
50%
€1.00
Target price
31.12.25
€2.90
Performance (%)
-61.99%
End price
03.01.26
€0.38
Summary
This prediction ended on 03.01.26 with a price of €0.38. The BUY prediction by Jefferies_Financial_ for Sangamo Therapeutics Inc. performed very badly with a performance of -61.99%. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | 0.491% | 0.491% | -64.314% |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,95 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 9,58 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 20,32 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 5,80 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Jefferies Financial Group Inc. from $7.00 to $3.00. They now have a "buy" rating on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten